CVS exec: Our new reliance on cost effectiveness should make drug makers ‘think about launch prices’

In a bid to dampen rising drug costs, CVS Caremark plans to allow its clients — such as health plans and employers — to exclude from their formularies any new medicine that has a higher price than a particular benchmark for determining value.

Continue reading on Stat News.